Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Journal articles
, 2026, 'Outreach mpox vaccination at sex-on-premises venues in Sydney: an audit of a collaborative intervention by public health nurses and LGBTQI+ peer workers', BMC Public Health, 26, http://dx.doi.org/10.1186/s12889-026-26525-y
, 2026, 'Case Report: Reintroduction of winged infusion sets to needle syringe programs - advancing equity in harm reduction', Frontiers in Psychiatry, 17, http://dx.doi.org/10.3389/fpsyt.2026.1741947
, 2026, 'Syphilis in adults: updates on testing, prevention and treatment', Internal Medicine Journal, 56, pp. 544 - 551, http://dx.doi.org/10.1111/imj.70358
, 2026, 'Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on Opioids', Drug and Alcohol Review, 45, http://dx.doi.org/10.1111/dar.70079
, 2026, 'Drivers, barriers, and implications of mpox vaccine uptake in Australia among gay, bisexual, and other men who have sex with men: results from a prospective observational mixed-methods study (2022–2024)', Vaccine, 70, pp. 128041 - 128041, http://dx.doi.org/10.1016/j.vaccine.2025.128041
, 2025, 'Characteristics of take-home fentanyl test strip use and support for drug checking services among people who use heroin in Australia: learnings for an increasingly complex drug market', Harm Reduction Journal, 22, pp. 75, http://dx.doi.org/10.1186/s12954-025-01205-z
, 2025, 'The impact of opioid agonist treatment on the incidence of bacterial sexually transmitted infection notifications among people with a history of opioid dependence in New South Wales, Australia: A retrospective data linkage study', Drug and Alcohol Dependence, 277, http://dx.doi.org/10.1016/j.drugalcdep.2025.112929
, 2025, 'The mpox vaccine: when protection becomes selective', Lancet Primary Care, 1, http://dx.doi.org/10.1016/j.lanprc.2025.100053
, 2025, 'Clinical features of mpox in fully vaccinated people in New South Wales, Australia: an outbreak investigation and retrospective cohort study', Lancet Primary Care, 1, http://dx.doi.org/10.1016/j.lanprc.2025.100018
, 2025, 'Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study', International Journal of Drug Policy, 143, http://dx.doi.org/10.1016/j.drugpo.2025.104859
, 2025, 'Sexually transmitted infection prevalence and testing coverage among people who inject drugs: A systematic review', Drug and Alcohol Dependence, 273, http://dx.doi.org/10.1016/j.drugalcdep.2025.112732
, 2025, 'Hepatitis B susceptibility and subsequent vaccination in priority populations across an Australian sentinel surveillance network, 2017-2023', Epidemiology and Infection, 153, http://dx.doi.org/10.1017/S0950268825100241
, 2024, 'Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023)', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae665
, 2024, 'Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot', BMC Infectious Diseases, 24, http://dx.doi.org/10.1186/s12879-024-08989-8
, 2024, 'Coverage of cervical cancer prevention interventions among people in Australia who inject drugs', International Journal of Drug Policy, 132, http://dx.doi.org/10.1016/j.drugpo.2024.104566
, 2024, 'Syphilis testing, incidence, and reinfection among gay and bisexual men in Australia over a decade spanning HIV PrEP implementation: an analysis of surveillance data from 2012 to 2022', Lancet Regional Health Western Pacific, 51, http://dx.doi.org/10.1016/j.lanwpc.2024.101175
, 2024, 'Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs', International Journal of Drug Policy, 128, http://dx.doi.org/10.1016/j.drugpo.2024.104468
, 2024, 'Hepatitis C (HCV) Reinfection and Risk Factors among Clients of a Low-Threshold Primary Healthcare Service for People Who Inject Drugs in Sydney, Australia', Viruses, 16, http://dx.doi.org/10.3390/v16060957
, 2024, 'Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis', Eclinicalmedicine, 72, http://dx.doi.org/10.1016/j.eclinm.2024.102596
, 2024, 'Critical Success Factors for Intersectoral Collaboration: Homelessness and COVID-19 – Case Studies and Learnings from an Australian City', International Journal of Integrated Care, 24, pp. 19, http://dx.doi.org/10.5334/ijic.7653
, 2024, 'Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs: The ETHOS engage study', International Journal of Drug Policy, 127, http://dx.doi.org/10.1016/j.drugpo.2024.104394
, 2024, 'Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study', Drug and Alcohol Review, 43, pp. 1019 - 1028, http://dx.doi.org/10.1111/dar.13828
, 2024, 'Investigation and response to an outbreak of Neisseria meningitidis serogroup Y ST-1466 urogenital infections, Australia', Communicable Diseases Intelligence 2018, 48, http://dx.doi.org/10.33321/cdi.2024.48.20
, 2024, 'Chlamydia retesting remains low among young women in Australia: an observational study using sentinel surveillance data, 2018–2022', Sexual Health, 21, http://dx.doi.org/10.1071/SH23178
, 2024, 'Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study', Value in Health, 27, pp. 216 - 225, http://dx.doi.org/10.1016/j.jval.2023.10.013
, 2023, 'Evaluating the prevalence of current hepatitis C infection and treatment among Aboriginal and Torres Strait Islander peoples who inject drugs in Australia: The ETHOS engage study', Drug and Alcohol Review, 42, pp. 1617 - 1632, http://dx.doi.org/10.1111/dar.13723
, 2023, 'Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study', Open Forum Infectious Diseases, 10, http://dx.doi.org/10.1093/ofid/ofad517
, 2023, 'How Australia and Aotearoa New Zealand avoided large-scale mpox (formerly monkeypox) outbreaks in 2022–2023', Internal Medicine Journal, 53, pp. 1732 - 1738, http://dx.doi.org/10.1111/imj.16236
, 2023, 'Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis', Lancet Microbe, 4, pp. e622 - e631, http://dx.doi.org/10.1016/S2666-5247(23)00108-8
, 2023, 'Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs', Value in Health, 26, pp. 883 - 892, http://dx.doi.org/10.1016/j.jval.2022.12.016
, 2023, 'Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study', International Journal of Drug Policy, 114, http://dx.doi.org/10.1016/j.drugpo.2023.103982
, 2023, 'Infectious syphilis in women and heterosexual men in major Australian cities: sentinel surveillance data, 2011–2019', Medical Journal of Australia, 218, pp. 223 - 228, http://dx.doi.org/10.5694/mja2.51864
, 2023, 'Characteristics of Human Immunodeficiency Virus (HIV) Seroconversions in a Large Prospective Implementation Cohort Study of Oral HIV Preexposure Prophylaxis in Men Who Have Sex with Men (EPIC-NSW)', Clinical Infectious Diseases, 76, pp. E622 - E628, http://dx.doi.org/10.1093/cid/ciac660
, 2023, 'Effectiveness of direct-acting antiviral therapy among Aboriginal and Torres Strait Islander peoples with HCV infection in Australia: A national real-world cohort (REACH-C)', Journal of Viral Hepatitis, 30, pp. 386 - 396, http://dx.doi.org/10.1111/jvh.13803
, 2023, 'Syphilis If you don't look for it, you'll miss it', Medicine Today, 24, pp. 38 - 42
, 2022, 'Awareness of hepatitis C virus infection status among people who inject drugs in a setting of universal direct-acting antiviral therapy: The ETHOS Engage study', International Journal of Drug Policy, 110, http://dx.doi.org/10.1016/j.drugpo.2022.103876
, 2022, 'Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study', Viruses, 14, http://dx.doi.org/10.3390/v14112463
, 2022, 'Low Prior Exposure and Incidence of Hepatitis C in Human Immunodeficiency Virus–Negative Gay and Bisexual Men Taking Preexposure Prophylaxis (PrEP): Findings from the Expanded PrEP Implementation in Communities–New South Wales Prospective Implementation Study', Clinical Infectious Diseases, 75, pp. 1497 - 1502, http://dx.doi.org/10.1093/cid/ciac231
, 2022, 'Patterns and correlates of hepatitis C virus phylogenetic clustering among people living with HIV in Australia in the direct-acting antiviral era: A molecular epidemiology study among participants in the CEASE cohort', Health Science Reports, 5, http://dx.doi.org/10.1002/hsr2.719
, 2022, 'Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study', Drug and Alcohol Dependence, 237, http://dx.doi.org/10.1016/j.drugalcdep.2022.109543
, 2022, 'Retreatment for hepatitis C virus direct-acting antiviral therapy virological failure in primary and tertiary settings: The REACH-C cohort', Journal of Viral Hepatitis, 29, pp. 661 - 676, http://dx.doi.org/10.1111/jvh.13705
, 2022, 'A Testing Campaign Intervention Consisting of Peer-Facilitated Engagement, Point-of-Care HCV RNA Testing, and Linkage to Nursing Support to Enhance Hepatitis C Treatment Uptake among People Who Inject Drugs: The ETHOS Engage Study', Viruses, 14, http://dx.doi.org/10.3390/v14071555
, 2022, 'The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions', Drug and Alcohol Review, 41, pp. 1085 - 1094, http://dx.doi.org/10.1111/dar.13474
, 2022, 'High Effectiveness of Broad Access Direct-Acting Antiviral Therapy for Hepatitis C in an Australian Real-World Cohort: The REACH-C Study', Hepatology Communications, 6, pp. 496 - 512, http://dx.doi.org/10.1002/hep4.1826
, 2022, '‘Lifting the invisibility cloak’ on the pivotal role of nurses in hepatitis C (HCV) testing, diagnosis and management – findings from an integrated primary healthcare service for marginalised people in inner Sydney, Australia', Australian Journal of Advanced Nursing, 39, http://dx.doi.org/10.37464/2020.394.785
, 2022, 'Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study', International Journal of Drug Policy, 105, pp. 103706, http://dx.doi.org/10.1016/j.drugpo.2022.103706
, 2021, 'Hepatitis C virus cascade of care among people who inject drugs in Australia: Factors associated with testing and treatment in a universal healthcare system', Drug and Alcohol Dependence, 228, http://dx.doi.org/10.1016/j.drugalcdep.2021.109050
, 2021, 'Effectiveness of treatment for hepatitis C virus reinfection following direct acting antiviral therapy in the REACH-C cohort', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103422
, 2021, 'Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103421
, 2021, 'Sofosbuvir/velpatasvir for 12 vs. 6 weeks for the treatment of recently acquired hepatitis C infection', Journal of Hepatology, 75, pp. 829 - 839, http://dx.doi.org/10.1016/j.jhep.2021.04.056